S&P 500
(0.11%) 5 254.35 points
Dow J
(0.12%) 39 807 points
Nasdaq
(-0.12%) 16 379 points
Oil
(-0.07%) $83.11
Gas
(-0.62%) $1.752
Gold
(0.73%) $2 254.80
Silver
(0.74%) $25.10
Platinum
(0.21%) $923.00
USD/EUR
(-0.02%) $0.926
USD/NOK
(-0.08%) $10.83
USD/GBP
(-0.11%) $0.791
USD/RUB
(-0.21%) $92.38

Realtime updates for LianBio [LIAN]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
Last Updated26 Mar 2024 @ 16:00

-8.28% $ 0.319


Warning: Undefined array key 1 in /home/getagraph/public_html/signalbox.php on line 10
SELL 63360 min ago

@ $4.83

Issued: 14 Feb 2024 @ 09:35


Return: -93.39%


Live Chart Being Loaded With Signals

Commentary (26 Mar 2024 @ 16:00):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302
Profile picture for LianBio

LianBio, a biopharmaceutical company, engages in developing and commercializing medicines for cardiovascular, oncology, respiratory, opthalmology, and inflammatory diseases in China and other Asian countries...

Stats
Today's Volume 2.48M
Average Volume 963 531
Market Cap 34.47M
EPS $0 ( 2024-03-25 )
Next earnings date ( $0 ) 2024-05-09
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -0.390
ATR14 $0.00600 (1.80%)
Insider Trading
Date Person Action Amount type
2024-02-15 Poukalov Konstantin Buy 36 300 Ordinary Shares
2024-02-15 Poukalov Konstantin Sell 19 218 Ordinary Shares
2024-02-15 Poukalov Konstantin Sell 36 300 Stock Option (Right to Buy)
2024-02-15 Perceptive Advisors Llc Buy 36 300 Ordinary Shares
2024-02-15 Perceptive Advisors Llc Sell 19 218 Ordinary Shares
INSIDER POWER
73.97
Last 77 transactions
Buy: 50 859 501 | Sell: 7 415 331

Volume Correlation

Long: 0.35 (neutral)
Short: 0.36 (neutral)
Signal:(47.977) Neutral

LianBio Correlation

10 Most Positive Correlations
IPHA0.872
PRDS0.853
ORIC0.841
AMRB0.836
CHRS0.811
BGNE0.801
10 Most Negative Correlations
EMBC-0.83

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

LianBio Correlation - Currency/Commodity

The country flag 0.08
( neutral )
The country flag -0.17
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag -0.06
( neutral )

LianBio Financials

Annual 2022
Revenue: $0
Gross Profit: $-1.00M (0.00 %)
EPS: $-1.020
Q3 2023
Revenue: $0
Gross Profit: $-300 018 (0.00 %)
EPS: $-0.220
Q2 2023
Revenue: $0
Gross Profit: $-296 781 (0.00 %)
EPS: $-0.200
Q1 2023
Revenue: $0
Gross Profit: $-323 366 (0.00 %)
EPS: $-0.220

Financial Reports:

No articles found.

LianBio

LianBio, a biopharmaceutical company, engages in developing and commercializing medicines for cardiovascular, oncology, respiratory, opthalmology, and inflammatory diseases in China and other Asian countries. The company develops mavacamten for the treatment of obstructive and non-obstructive hypertrophic cardiomyopathy, and heart failure with preserved ejection fraction; TP-03 for the treatment of Demodex blepharitis; NBTXR3 for the treatment of head and neck squamous cell carcinoma, and solid tumor; Infigratinib for the treatment of second-line and first-line cholangiocarcinoma, and gastric cancers; BBP-398 for solid tumors; Omilancor for ulcerative colitis and Crohn's disease; NX-13 for ulcerative colitis; LYR-210 for chronic rhinosinusitis; and Sisunatovir for respiratory syncytical virus. It has a partnership with Tarsus Pharmaceuticals, Inc. to develop and commercialize TP-03, an eye solution for the treatment of Demodex blepharitis; and Nanobiotix S.A. to develop and commercialize NBTXR3, a radioenhancer designed to be injected directly into a malignant tumor prior to standard radiotherapy. The company was incorporated in 2019 and is headquartered in Princeton, New Jersey.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators